Jan 31, 2022 8:00am EST 180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Shareholders
Dec 28, 2021 11:00am EST 180 Life Sciences Corp. To Participate in the Biotech Showcase 2022 Virtual Conference To be Held January 10-12, 2022
Dec 15, 2021 8:15am EST 180 Life Sciences Corp. Enters into a License Agreement with University of Oxford for Regenerative Molecule HMGB1 for Liver Diseases
Dec 06, 2021 8:15am EST 180 Life Sciences Provides Follow-Up Information on Oxford University and the Company’s Successful Dupuytren’s Phase 2b Clinical Trial Results
Dec 01, 2021 2:45pm EST 180 Life Sciences Corp. Co-Founder Prof. Jagdeep Nanchahal Presents Keynote Address at the 2021 International Dupuytren Symposium, Including Top Line Data From the Phase 2b Clinical Trial
Nov 18, 2021 8:15am EST 180 Life Sciences Corp. Co-Founder Prof. Jagdeep Nanchahal to Present a Keynote Address at the 2021 International Dupuytren Symposium
Nov 03, 2021 12:06pm EDT 180 Life Sciences Corp. Names Quan A. Vu Chief Operating Officer/Chief Business Officer
Oct 26, 2021 8:30am EDT 180 Life Sciences Corp. Publishes Pre-Clinical Study Report on the Effects of CBG Derivatives on Pain, Inflammation and Obesity in The Journal Molecules